Targeting Nociceptin/Orphanin FQ receptor to rescue cognitive symptoms in a mouse neuroendocrine model of chronic stress

被引:2
|
作者
da Silva, Flora D'Oliveira [1 ]
Robert, Cathaline [1 ]
Lardant, Emma [2 ]
Pizzano, Carina [3 ]
Bruchas, Michael R. [3 ]
Guiard, Bruno P. [1 ]
Chauveau, Frederic [2 ]
Mouledous, Lionel [1 ]
机构
[1] Univ Toulouse, Res Ctr Anim Cognit CRCA, Ctr Integrat Biol CBI, CNRS,UPS,UMR 5169, Toulouse, France
[2] IRBA Army Biomed Res Inst, Bretigny Sur Orge, France
[3] Univ Washington, Ctr Excellence Neurobiol Addict Pain & Emot NAPE, Dept Anesthesiol, Seattle, WA 98195 USA
关键词
MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; ORPHANIN-FQ; NOP RECEPTOR; MEMORY; HIPPOCAMPUS; NEURONS; GLUCOCORTICOIDS; INVOLVEMENT; DISORDERS;
D O I
10.1038/s41380-023-02363-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic stress causes cognitive deficits, such as impairments in episodic-like hippocampus-dependent memory. Stress regulates an opioid-related neuropeptide named Nociceptin/Orphanin FQ (N/OFQ), the ligand of the G protein-coupled receptor NOP. Since this peptide has deleterious effects on memory, we hypothesized that the N/OFQ system could be a mediator of the negative effects of stress on memory. Chronic stress was mimicked by chronic exposure to corticosterone (CORT). The NOP receptor was either acutely blocked using selective antagonists, or knocked-down specifically in the hippocampus using genetic tools. Long-term memory was assessed in the object recognition (OR) and object location (OL) paradigms. Acute injection of NOP antagonists before learning had a negative impact on memory in naive mice whereas it restored memory performances in the chronic stress model. This rescue was associated with a normalization of neuronal cell activity in the CA3 part of the hippocampus. Chronic CORT induced an upregulation of the N/OFQ precursor in the hippocampus. Knock-down of the NOP receptor in the CA3/Dentate Gyrus region prevented memory deficits in the CORT model. These data demonstrate that blocking the N/OFQ system can be beneficial for long-term memory in a neuroendocrine model of chronic stress. We therefore suggest that NOP antagonists could be useful for the treatment of memory deficits in stress-related disorders.
引用
收藏
页码:718 / 729
页数:12
相关论文
共 50 条
  • [31] Differential Effects of Nociceptin/Orphanin FQ (NOP) Receptor Agonists in Acute versus Chronic Pain: Studies with Bifunctional NOP/μ Receptor Agonists in the Sciatic Nerve Ligation Chronic Pain Model in Mice
    Khroyan, Taline V.
    Polgar, Willma E.
    Orduna, Juan
    Montenegro, Jose
    Jiang, Faming
    Zaveri, Nurulain T.
    Toll, Lawrence
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (02): : 687 - 693
  • [32] Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111
    Marti, M.
    Mela, F.
    Budri, M.
    Volta, M.
    Malfacini, D.
    Molinari, S.
    Zaveri, N. T.
    Ronzoni, S.
    Petrillo, P.
    Calo, G.
    Morari, M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (04) : 863 - 879
  • [33] Effects of Stress Exposure to Pain Perception in Pre-Clinical Studies: Focus on the Nociceptin/Orphanin FQ-NOP Receptor System
    Pola, Pietro
    Frezza, Alessia
    Gavioli, Elaine C.
    Calo, Girolamo
    Ruzza, Chiara
    BRAIN SCIENCES, 2024, 14 (09)
  • [34] Nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) knockout mice display impaired renal excretory and enhanced cardiovascular responses to stress
    Burmeister, MA
    Ansonoff, M
    Pintar, J
    Kapusta, DR
    FASEB JOURNAL, 2006, 20 (04): : A359 - A359
  • [35] The nociceptin/orphanin FQ receptor system as a target to alleviate cancer-induced bone pain in rats: Model validation and pharmacological evaluation
    Sliepen, Sonny H. J.
    Korioth, Johanna
    Christoph, Thomas
    Tzschentke, Thomas M.
    Diaz-delCastillo, Marta
    Heegaard, Anne-Marie
    Rutten, Kris
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (09) : 1995 - 2007
  • [36] Fear expression is reduced after acute and repeated nociceptin/orphanin FQ (NOP) receptor antagonism in rats: therapeutic implications for traumatic stress exposure
    Taylor, Rachel M.
    Jeong, Isaac H.
    May, Matthew D.
    Bergman, Elizabeth M.
    Capaldi, Vincent F.
    Moore, Nicole L. T.
    Matson, Liana M.
    Lowery-Gionta, Emily G.
    PSYCHOPHARMACOLOGY, 2020, 237 (10) : 2943 - 2958
  • [37] Therapeutic potential of nociceptin/orphanin FQ peptide (NOP) receptor modulators for treatment of traumatic brain injury, traumatic stress, and their co-morbidities
    Al Yacoub, Omar N.
    Awwad, Hibah O.
    Zhang, Yong
    Standifer, Kelly M.
    PHARMACOLOGY & THERAPEUTICS, 2022, 231
  • [38] Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198
    Roberto Ciccocioppo
    Michela Biondini
    Lorena Antonelli
    Juergen Wichmann
    François Jenck
    Maurizio Massi
    Psychopharmacology, 2002, 161 : 113 - 119
  • [39] Fear expression is reduced after acute and repeated nociceptin/orphanin FQ (NOP) receptor antagonism in rats: therapeutic implications for traumatic stress exposure
    Rachel M. Taylor
    Isaac H. Jeong
    Matthew D. May
    Elizabeth M. Bergman
    Vincent F. Capaldi
    Nicole L.T. Moore
    Liana M. Matson
    Emily G. Lowery-Gionta
    Psychopharmacology, 2020, 237 : 2943 - 2958
  • [40] Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198
    Ciccocioppo, R
    Biondini, M
    Antonelli, L
    Wichmann, J
    Jenck, F
    Massi, M
    PSYCHOPHARMACOLOGY, 2002, 161 (02) : 113 - 119